Design strategies for programmable oligonucleotide nanotherapeutics.


Journal

Drug discovery today
ISSN: 1878-5832
Titre abrégé: Drug Discov Today
Pays: England
ID NLM: 9604391

Informations de publication

Date de publication:
01 2020
Historique:
received: 12 03 2019
revised: 02 08 2019
accepted: 09 09 2019
pubmed: 17 9 2019
medline: 4 5 2021
entrez: 17 9 2019
Statut: ppublish

Résumé

A systematic review on how to design different programmable nanotherapeutics using oligonucleotides as building blocks or as surface and matrix modifiers for controlled and targeted delivery of various therapeutic agents in presented.

Identifiants

pubmed: 31525462
pii: S1359-6446(19)30350-2
doi: 10.1016/j.drudis.2019.09.006
pmc: PMC6980509
mid: NIHMS1539903
pii:
doi:

Substances chimiques

Oligonucleotides 0
DNA 9007-49-2

Types de publication

Journal Article Research Support, N.I.H., Extramural Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-88

Subventions

Organisme : NEI NIH HHS
ID : R01 EY023853
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Références

Chem Commun (Camb). 2013 Mar 11;49(20):2010-2
pubmed: 23380739
Ann N Y Acad Sci. 2007 Dec;1122:197-218
pubmed: 18077574
J Control Release. 2014 Dec 28;196:234-42
pubmed: 25450401
PLoS One. 2015 Sep 25;10(9):e0139136
pubmed: 26406332
J Am Chem Soc. 2012 Oct 10;134(40):16488-91
pubmed: 23020598
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015 May-Jun;7(3):282-97
pubmed: 25327363
Eur J Pharm Biopharm. 2014 Feb;86(2):244-50
pubmed: 23896195
Biophys J. 2006 Feb 1;90(3):1000-8
pubmed: 16287814
Nano Lett. 2011 Apr 13;11(4):1477-82
pubmed: 21366226
Biotechnol J. 2019 Jan;14(1):e1700634
pubmed: 29802763
J Mater Chem B. 2017 Jun 28;5(24):4713-4724
pubmed: 32264314
Nano Lett. 2009 Jan;9(1):308-11
pubmed: 19099465
Science. 2015 Feb 20;347(6224):1260901
pubmed: 25700524
Nano Lett. 2018 Jun 13;18(6):3557-3564
pubmed: 29756442
Angew Chem Int Ed Engl. 2017 Oct 2;56(41):12528-12532
pubmed: 28806476
Eur J Pharm Sci. 2016 Sep 20;92:98-109
pubmed: 27393341
Biomicrofluidics. 2013 Mar;7(2):26501
pubmed: 23573176
Nat Commun. 2011 Jun 07;2:339
pubmed: 21654639
Eur J Pharm Biopharm. 2012 Sep;82(1):139-50
pubmed: 22691416
Biomacromolecules. 2017 Feb 13;18(2):483-489
pubmed: 27931093
Biomater Sci. 2016 Apr;4(4):605-9
pubmed: 26674121
ACS Nano. 2011 Nov 22;5(11):8783-9
pubmed: 21988181
ACS Appl Mater Interfaces. 2019 Mar 27;11(12):11112-11118
pubmed: 30874429
Bioconjug Chem. 2001 Nov-Dec;12(6):917-23
pubmed: 11716682
J Am Chem Soc. 2016 Feb 17;138(6):1764-7
pubmed: 26824749
Oncotarget. 2016 Jun 21;7(25):38257-38269
pubmed: 27203221
Exp Mol Med. 2016 May 06;48:e230
pubmed: 27151454
ACS Appl Mater Interfaces. 2013 Oct 9;5(19):9295-304
pubmed: 24041191
Eur J Pharm Biopharm. 2000 Jul;50(1):161-77
pubmed: 10840199
Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):3892-7
pubmed: 25775582
Drug Discov Today. 2019 Jan;24(1):129-147
pubmed: 30292916
Angew Chem Int Ed Engl. 2006 Nov 13;45(44):7414-7
pubmed: 17086586
Nano Lett. 2012 Aug 8;12(8):4254-9
pubmed: 22746330
Materials (Basel). 2019 Mar 21;12(6):
pubmed: 30901888
Adv Mater. 2010 Nov 9;22(42):4754-8
pubmed: 20839255
Nanoscale Res Lett. 2011 Oct 13;6:555
pubmed: 21995320
Pharm Res. 2013 Feb;30(2):538-51
pubmed: 23135817
Nanoscale. 2018 Dec 20;11(1):339-347
pubmed: 30534748
Pharmaceutics. 2017 Mar 27;9(2):
pubmed: 28346375
J Am Chem Soc. 2012 Feb 15;134(6):2888-91
pubmed: 22283197
Drug Dev Ind Pharm. 2018 Jan;44(1):13-18
pubmed: 28832225
Langmuir. 2005 Sep 27;21(20):9183-6
pubmed: 16171349
Small. 2015 Oct 28;11(40):5360-8
pubmed: 26297167
Pharm Res. 2014 Mar;31(3):531-40
pubmed: 23996470
J Am Chem Soc. 2012 Aug 15;134(32):13396-403
pubmed: 22803823
Mol Pharm. 2018 Apr 2;15(4):1467-1475
pubmed: 29320631
Methodist Debakey Cardiovasc J. 2016 Sep;12(3):157-162
pubmed: 27826370
Bioconjug Chem. 1998 Sep-Oct;9(5):513-38
pubmed: 9736486
Mater Sci Eng C Mater Biol Appl. 2016 Feb;59:324-332
pubmed: 26652380
Int J Pharm. 2017 Apr 15;521(1-2):156-166
pubmed: 28223247
Open Nanomed J. 2011 Jan 1;3:38-64
pubmed: 23807899
J Biomech Eng. 2004 Feb;126(1):104-10
pubmed: 15171136
ACS Nano. 2011 Aug 23;5(8):6156-63
pubmed: 21732610
J Am Chem Soc. 2014 May 28;136(21):7615-8
pubmed: 24827740
Biomaterials. 2008 Jan;29(3):359-69
pubmed: 17964645
Adv Mater. 2017 Feb;29(5):
pubmed: 27882622
Biochemistry. 2016 Mar 8;55(9):1326-31
pubmed: 26789283
Nanoscale. 2017 Jan 7;9(1):172-182
pubmed: 27905610
Nature. 2006 Mar 16;440(7082):297-302
pubmed: 16541064
Nat Nanotechnol. 2012 Jun 03;7(6):389-93
pubmed: 22659608
Drug Discov Today. 2018 May;23(5):992-1006
pubmed: 29653291
Langmuir. 2012 Nov 27;28(47):16463-8
pubmed: 23145990
Nanoscale. 2017 Jun 14;9(23):7750-7754
pubmed: 28581004
Small. 2016 Oct;12(40):5601-5611
pubmed: 27571230
Small. 2016 Jan 20;12(3):308-20
pubmed: 26583570
ACS Nano. 2012 Oct 23;6(10):8684-91
pubmed: 22950811
Int J Pharm. 2017 Jan 10;516(1-2):21-31
pubmed: 27845215
Nano Lett. 2007 Dec;7(12):3818-21
pubmed: 17997588
ACS Nano. 2014 Jul 22;8(7):6633-43
pubmed: 24963790
Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6644-8
pubmed: 17404217
J Control Release. 2014 Jul 10;185:12-21
pubmed: 24768792
Biomacromolecules. 2012 Nov 12;13(11):3533-41
pubmed: 23066958
Adv Mater. 2017 Jun;29(24):
pubmed: 28397966
Int J Pharm. 2017 Mar 15;519(1-2):352-364
pubmed: 28126548
Exp Biol Med (Maywood). 2016 May;241(10):1127-37
pubmed: 27190245
Chem Commun (Camb). 2016 Dec 1;52(98):14161-14164
pubmed: 27869278
Biomacromolecules. 2009 Mar 9;10(3):505-16
pubmed: 19216528
Proc Natl Acad Sci U S A. 2013 May 7;110(19):7625-30
pubmed: 23613589
Biomaterials. 2011 Jan;32(2):516-27
pubmed: 21030073
Chem Sci. 2017 Feb 1;8(2):1062-1067
pubmed: 28451245
Chem Commun (Camb). 2009 Dec 7;(45):7036-8
pubmed: 19904386
Adv Drug Deliv Rev. 2017 Dec 1;122:31-64
pubmed: 28392306
Eur J Pharm Biopharm. 2017 Jun;115:122-130
pubmed: 28189623
Nat Nanotechnol. 2011 May;6(5):268-76
pubmed: 21499251
Nat Nanotechnol. 2015 Sep;10(9):741-7
pubmed: 26329110
Nanoscale. 2016 Apr 28;8(17):9037-95
pubmed: 27080924
ACS Nano. 2016 Mar 22;10(3):3486-95
pubmed: 26950644
Nano Lett. 2010 Jul 14;10(7):2690-3
pubmed: 20518544
Angew Chem Int Ed Engl. 2013 Jul 1;52(27):6854-7
pubmed: 23716499
Biomacromolecules. 2008 Nov;9(11):3039-43
pubmed: 18821795
Food Chem. 2017 Jul 15;227:9-15
pubmed: 28274463
Nat Biotechnol. 2018 Mar;36(3):258-264
pubmed: 29431737
ACS Nano. 2013 Feb 26;7(2):1379-87
pubmed: 23379679
Nano Lett. 2012 Jul 11;12(7):3867-71
pubmed: 22725653
J Am Chem Soc. 2012 Sep 26;134(38):15716-9
pubmed: 22970862
Adv Mater. 2013 Aug 27;25(32):4386-96
pubmed: 23765613
J Am Chem Soc. 2014 Jul 16;136(28):9866-9
pubmed: 24983505
Cell Prolif. 2019 Jan;52(1):e12511
pubmed: 30311693
Angew Chem Int Ed Engl. 2010 Nov 8;49(46):8574-87
pubmed: 20845335
ACS Nano. 2011 Dec 27;5(12):9696-702
pubmed: 22092186
Anal Chem. 2015;87(9):4925-32
pubmed: 25853548
Biomater Sci. 2014 Feb 23;2(2):203-211
pubmed: 32481880

Auteurs

Fitsum Feleke Sahle (FF)

Department of Pharmaceutical Sciences, University of Tennessee Health Sciences Center, Memphis, TN 38163, USA.

Tao L Lowe (TL)

Department of Pharmaceutical Sciences, University of Tennessee Health Sciences Center, Memphis, TN 38163, USA. Electronic address: tlowe4@uthsc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH